piracetam has been researched along with mecamylamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartolini, A; Bellucci, C; Dei, S; Galeotti, N; Ghelardini, C; Gualtieri, F; Manetti, D; Romanelli, MN; Scapecchi, S; Teodori, E | 1 |
| Nishizaki, T; Nomura, T | 1 |
| Hsieh, CC; Hsieh, MT; Lin, LW; Tsai, CH; Wu, CR | 1 |
3 other study(ies) available for piracetam and mecamylamine
| Article | Year |
|---|---|
Design, synthesis, and preliminary pharmacological evaluation of 1, 4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic agents.
Topics: Adrenergic alpha-Agonists; Amnesia; Animals; Avoidance Learning; Baclofen; Clonidine; Dose-Response Relationship, Drug; Drug Design; GABA Agonists; Mecamylamine; Mice; Molecular Structure; Muscarinic Antagonists; Nicotine; Nootropic Agents; Piperazines; Piracetam; Pyrroles; Scopolamine | 2000 |
Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action.
Topics: Animals; Bungarotoxins; Gene Expression; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Mecamylamine; Membrane Potentials; Neurons; Nicotinic Antagonists; Nootropic Agents; Oocytes; Patch-Clamp Techniques; Piracetam; Pyrrolidinones; Rats; Rats, Wistar; Receptors, Nicotinic; Synaptic Transmission; Xenopus | 2000 |
Reversal caused by n-butylidenephthalide from the deficits of inhibitory avoidance performance in rats.
Topics: Animals; Avoidance Learning; Cholinergic Antagonists; Male; Mecamylamine; Phthalic Anhydrides; Piracetam; Rats; Rats, Sprague-Dawley; Scopolamine | 2001 |